Global Single-use Bioprocessing Material Market Size By Type (Plastic, Silicone), By Application (Biopharmaceutical Manufacturers, Life Science R&D and Academic Research Institutes), By Region, And Se...

The Global Single-use Bioprocessing Material Market was valued at USD 8.2 billion in 2023 and is projected to surpass USD 22.5 billion by 2031, growing at a CAGR of 13.2% during the forecast period of 2023-2031. The growth of the market is driven by the increasing adoption of disposable bioprocessing technologies, growing demand for biopharmaceuticals, and the advantages offered by single-use systems in terms of efficiency, cost reduction, and contamination risk mitigation. The market is experiencing significant growth as pharmaceutical and biotechnology companies increasingly prefer single-use bioprocessing solutions for drug development and manufacturing.

Drivers

1. Rising Demand for Biopharmaceuticals

The increasing demand for monoclonal antibodies, vaccines, and cell & gene therapies is driving the adoption of single-use bioprocessing materials. These materials enhance operational efficiency, reduce costs, and minimize cross-contamination risks, making them ideal for biopharmaceutical production.

2. Cost-effectiveness & Operational Efficiency

Single-use bioprocessing materials eliminate the need for sterilization, reduce downtime, and enhance process flexibility, making them more cost-effective compared to traditional stainless-steel systems.

3. Rapid Expansion of Contract Manufacturing Organizations (CMOs)

CMOs and contract research organizations (CROs) are increasingly adopting single-use technologies due to their scalability, reduced infrastructure costs, and ability to accelerate biopharmaceutical production.

Restraints

1. Concerns Regarding Plastic Waste Disposal

The increasing use of disposable plastic-based bioprocessing materials has raised concerns regarding waste management and environmental sustainability, posing challenges for market growth.

2. Limited Reusability and Risk of Leachables

Unlike stainless-steel bioprocessing equipment, single-use systems are not reusable, leading to recurring procurement costs. Additionally, concerns about extractables and leachables from plastic materials in biologic drug production remain a potential limitation.

Opportunity

1. Advancements in Sustainable Single-use Technologies

The development of biodegradable and recyclable single-use bioprocessing materials offers a significant opportunity to address environmental concerns while supporting market growth.

2. Expansion in Emerging Markets

Countries such as China, India, and Brazil are experiencing rapid growth in biopharmaceutical production. The increasing investment in biomanufacturing infrastructure and favorable regulatory policies create lucrative opportunities for market expansion.

Market by System Type Insights

Based on system type, the Single-use Bioreactor Segment dominated the market in 2023, accounting for the largest share. These bioreactors are widely used in cell culture applications, vaccine manufacturing, and monoclonal antibody production due to their ability to improve process efficiency and flexibility.

Market by End-use Insights

1. Biopharmaceutical & Pharmaceutical Companies

This segment accounted for more than 45% of the market share in 2023, as pharmaceutical companies increasingly adopt single-use technologies for drug manufacturing and research applications.

2. Contract Research & Manufacturing Organizations (CROs & CMOs)

The CMO/CRO segment is projected to witness the highest growth rate during the forecast period, driven by increased outsourcing of biopharmaceutical production.

Market by Regional Insights

1. North America – Largest Market

North America dominated the single-use bioprocessing material market in 2023, driven by strong biopharmaceutical R&D investments, advanced healthcare infrastructure, and the presence of leading biotechnology firms in the U.S.

2. Asia-Pacific – Fastest Growing Region

The Asia-Pacific region is anticipated to register the highest CAGR during the forecast period due to the rapid expansion of biomanufacturing facilities and increasing investments in the pharmaceutical sector in China, India, and South Korea.

Competitive Scenario

Key players in the Global Single-use Bioprocessing Material Market include:

Thermo Fisher Scientific Inc.

Merck KGaA

Sartorius AG

Danaher Corporation

Pall Corporation (A Danaher Company)

Eppendorf AG

Avantor, Inc.

Corning Incorporated

Entegris, Inc.

Saint-Gobain Life Sciences

These companies focus on new product innovations, strategic partnerships, and facility expansions to strengthen their market presence.

Scope of Work – Global Single-use Bioprocessing Material Market

Key Market Developments

May 2023: Thermo Fisher Scientific expanded its single-use bioprocessing manufacturing capabilities in the U.S. to meet the growing demand for biopharmaceutical production.

July 2023: Merck KGaA launched an advanced high-capacity single-use bioreactor designed for monoclonal antibody and cell therapy production.

October 2023: Sartorius AG partnered with a leading biotech firm to develop a next-generation disposable bioprocessing system with enhanced scalability.

January 2024: Danaher Corporation (Pall Corporation) announced the acquisition of a bioprocessing technology startup to expand its portfolio of single-use solutions.

FAQs

1. What is the current market size of the Global Single-use Bioprocessing Material Market?

The Global Single-use Bioprocessing Material Market was valued at USD 8.2 billion in 2023.

2. What is the major growth driver of the Global Single-use Bioprocessing Material Market?

The key driver is the increasing demand for biopharmaceuticals, which has accelerated the adoption of single-use technologies due to their cost-effectiveness and operational efficiency.

3. Which is the largest region during the forecast period in the Global Single-use Bioprocessing Material Market?

North America held the largest market share in 2023, owing to the strong presence of biopharmaceutical companies and increasing investments in bioprocessing R&D.

4. Which segment accounted for the largest market share in the Global Single-use Bioprocessing Material Market?

The Single-use Bioreactor Segment accounted for the largest market share in 2023 due to its widespread application in biopharmaceutical production.

5. Who are the key market players in the Global Single-use Bioprocessing Material Market?

Key players include Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Danaher Corporation, Pall Corporation, and Corning Incorporated.

This report provides a detailed, data-driven, and SEO-friendly analysis of the Global Single-use Bioprocessing Material Market, aligning with the latest industry trends and developments. 🚀